Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Retinol may affect immune responses in people with frequent skin boils.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Innate lymphoid cells help us understand and manage allergic diseases better.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILK is essential for skin development, pigmentation, and healing.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

NLRP1 helps melanoma tumors grow by boosting inflammasome activation and reducing caspase-3 activity.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Different γδ T cell types have unique roles in causing alopecia areata.

CGF therapy may effectively treat psoriasis by reducing inflammation.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

MiR-23b and miR-133 affect sheep hair growth by targeting specific genes.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.